New treatment options in the management of hypertension: appraising the potential role of azilsartan medoxomil
Massimo Volpe1,2, Carmine Savoia11Division of Cardiology, Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, Sapienza University of Rome, Rome Italy; 2IRCCS Neuromed, Pozzilli (Is), ItalyAbstract: Renin–angiotensin–system (RAS) activation pla...
Main Authors: | Volpe M, Savoia C |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2012-03-01
|
Series: | Integrated Blood Pressure Control |
Online Access: | http://www.dovepress.com/new-treatment-options-in-the-management-of-hypertension-appraising-the-a9460 |
Similar Items
-
The treatment options of the new angiotensin II receptor blocker - azilsartan medoxomil in the therapy of hypertension in patients with metabolic disorders
by: Yu V Zhernakov, et al.
Published: (2014-12-01) -
COMBINATION OF AZILSARTAN MEDOXOMIL AND CHLORTHALIDONE: IS IT POSSIBLE TO FIGHT SYSTEMIC HYPERTENSION AND OBESITY TOGETHER?
by: Yu. A. Vasyuk, et al.
Published: (2017-10-01) -
MODERN OPPORTUNITIES FOR ANTIHYPERTENSION THERAPY: THE PLACE OF AZILSARTAN MEDOXOMIL
by: V. V. Skibitsky, et al.
Published: (2017-12-01) -
Experts of RMSAH opinion: the fixed combination of azilsartan medoxomil and chlortalidone is broadening options of the combined therapyin patients with arterial hypertension
by: I E Chazova, et al.
Published: (2015-09-01) -
Efficacy and safety of azilsartan medoxomil, an angiotensin receptor blocker, in Korean patients with essential hypertension
by: Attila Juhasz, et al.
Published: (2018-02-01)